Angel-backed Spartan Bioscience secures strategic investment from Canon
Spartan Bioscience Inc, an Ottawa-based provider of on-demand DNA testing technology, has received an undisclosed strategic investment from Canon USA Inc, a subsidiary of Japan's Canon Inc. The partnership is intended to help fund the research and development of new diagnostic testing products. Canon BioMedical Inc will focus on working with Spartan on these products, which will include rapid genetic testing. Founded in 2005, Spartan is a portfolio investment of Canadian angel organization Maple Leaf Angels.
19 March 2015•3 mins read
